Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers Determine Fundamental Mechanisms Involved in Immune Response

10.04.2003


Scientists from the Howard Hughes Medical Institute and their colleagues have unraveled some of the fundamental mysteries about the genetic mechanisms that endow the immune system with its life-saving ability to generate specialized antibodies.

Without genetic fine-tuning, antibodies would be relatively ineffective in finding a good match on the surface of viruses, parasites, and other potentially dangerous foreign pathogens. The findings also reveal the workings of a gene mutation process that can go awry, leading to the development of certain forms of cancer or allergic reactions.

HHMI investigator Frederick W. Alt at Children’s Hospital in Boston and Harvard Medical School directed the studies. His team’s findings explain the genetic line dance by which an otherwise generic immunoglobulin, or antibody, molecule acquires the genetic components that encode for the structural characteristics it needs to activate appropriate pathways to eliminate specific types of invaders, or antigens. The appropriate class of immunoglobulin can then mark invading cells for elimination by other cells of the immune system.



The researchers’ findings are published in two articles in the online editions of Nature Immunology and Nature on April 7 and April 9, 2003, respectively. Alt’s research team members include three current or former HHMI research associates, Jayanta Chaudhuri, Reiko Shinkura and Ming Tian.

The studies focus on how B cell lymphocytes, one of the major cell classes that is deployed in an immune response, assemble the genes that encode for the specific classes of Immunoglobulin on their surface. Unlike other genes, which retain their integrity through each cell division, multiple segments of immunoglobulin genes from disparate parts of the chromosome mix together numerous times to provide a diverse repertoire of functional antibodies. Subsequently, a second form gene shuffling creates various specialized classes of antibodies.

One part of the chromosomal gene segments encoding for immunoglobulin can vary enormously and provide specific recognition of foreign entities while the other remains relatively constant but can be changed in a few specific ways to provide specialization of the antibody. Alt’s papers address two hotly disputed controversies about the process of immunoglobulin specialization. The first controversy involves how the enzyme, activation-induced cytidine deaminase (AID), which is synthesized by the B cell, acts on a specialized region of immunoglobulin DNA, known as the constant region, to initiate the process of antibody specialization. The second is why the enzyme acts only on those particular DNA sequences and not on any others elsewhere in the genome.

For the Nature Immunology paper, Alt and colleagues studied mice to delineate specific gene structures and the alterations necessary for the regional gene swapping to occur. The Nature paper showed the results of the Alt team’s study of the effects of purified AID on test genetic (DNA) sequences.

In order for the specialized antibody properties to arise in immunoglobulins, the genes that encode for it must undergo a refining process known as class switch recombination (CSR). CSR is a highly specific blending of genes in which one part of the immunoglobulin DNA is swapped out for a more specialized class. Alt’s laboratory had previously shown that to activate immunoglobulin differentiation via CSR, a genetic transcription process is necessary within a highly localized region. However, little was known about the actual machinery of CSR or what role AID played in initiating the process.

Working with mice with targeted gene mutations, Alt’s group focused on the sequence of the DNA involved in CSR. When a B cell is activated by an antigen, specific double stranded segments of DNA in the immunoglobulin split off and loop out in a very controlled pattern known as an R-loop. One part of the strand is transcribed into RNA while another single strand of DNA is not transcribed. Alt’s team showed that transcription leading to the R-loop or other higher order DNA structures containing single-strand regions of DNA is important to generate the primary substrate needed for CSR to take place.

Alt’s team then showed, using AID protein, that AID actually modifies DNA and also has a strong preference for acting on the single-stranded segment of DNA. They also showed that AID cannot act on double-stranded segments unless they are transcribed. The AID catalyzed reactions on the single-stranded DNA to mutate it into a specialized form that can then be processed by normal cellular components to complete the CSR process.

The study demonstrates why the gene recombination occurs within such a tightly limited gene segment. It also proves that AID can function to target a specific DNA region to initiate the CSR process resulting in the immunoglobulin molecule’s antibody class specialization.

While this explains one of the fundamental mechanisms underlying the immune response, it also generates new avenues for understanding the genetic dislocations that can potentially initiate some forms of cancer. “The AID enzyme can be extremely dangerous,” says Alt. “It could potentially mutate or recombine any gene.” Were it to do so, it could contribute to genomic instability leading to cancer. Instability in the Immunoglobulin switch region is known to be involved in some forms of lymphoma. Alt’s laboratory is studying AID in laboratory mice to see how, when it goes awry, it could initiate a gene shuffling leading to cancer.

Understanding the immune response mechanism could also lead to new insights into allergic reactions. Allergies result from overproduction of immunoglobulin E, which causes an excessive response by the immune system to relatively benign antigens. Regulating CSR could potentially result in novel ways to treat allergies.

Jim Keeley | Howard Hughes Medical Institute
Further information:
http://www.hhmi.org/news/alt4.html

More articles from Life Sciences:

nachricht Designer cells: artificial enzyme can activate a gene switch
22.05.2018 | Universität Basel

nachricht Flow of cerebrospinal fluid regulates neural stem cell division
22.05.2018 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Designer cells: artificial enzyme can activate a gene switch

22.05.2018 | Life Sciences

PR of MCC: Carbon removal from atmosphere unavoidable for 1.5 degree target

22.05.2018 | Earth Sciences

Achema 2018: New camera system monitors distillation and helps save energy

22.05.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>